Liver Cirrhosis Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Liver Cirrhosis Market Expected To Expand Between 2025 And 2029?

The liver cirrhosis market has experienced substantial growth recently. It is projected to expand from $1.86 billion in 2024 to $1.99 billion in 2025, at a compound annual growth rate (CAGR) of 7.0%. This historical growth can be attributed to the increasing incidence of liver diseases, high levels of alcohol consumption, an aging global population, augmented healthcare expenditure, and the rise in government-led initiatives.

The liver cirrhosis market is anticipated to experience robust expansion in the upcoming years. Its valuation is projected to reach $2.68 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.7%. This projected increase throughout the forecast period stems from factors such as the increasing prevalence of hepatitis infections, a surge in economic growth, expanding urbanization, evolving lifestyle patterns, and the rise of medical tourism. Key developments expected during this period encompass progress in diagnostic instrumentation, breakthroughs in technology, strategic alliances and joint ventures, the incorporation of artificial intelligence, and the adoption of holistic treatment approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

What Are The Key Drivers Of Growth In The Liver Cirrhosis Market?

The anticipated increase in alcohol consumption is expected to propel the growth of the liver cirrhosis market going forward. Alcohol consumption refers to the intake of alcoholic beverages, typically measured by quantity and frequency. People are increasingly consuming alcohol because it helps them unwind from daily stress, fosters social connections in gatherings, and enhances moments of relaxation, while also benefiting from widespread media promotion and greater accessibility in various settings. Liver cirrhosis treatment for patients with excessive alcohol consumption focuses on managing liver damage through abstinence, medications, and supportive care, concurrently addressing alcohol dependence with counseling and rehabilitation. For instance, in March 2023, according to the National Drugs Library, an Ireland-based data collection organization, in 2022, the average alcohol consumption for individuals over 15 years old rose to 10.2 liters of pure alcohol per capita, reflecting a 7.6% increase from 2021. Therefore, increasing alcohol consumption drives the liver cirrhosis market.

What Are The Major Segment Categories Driving The Liver Cirrhosis Market Growth?

The liver cirrhosismarket covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis; Atrophic Cirrhosis; Biliary Cirrhosis; Cardiac Cirrhosis; Cryptogenic Cirrhosis

2) By Treatment: Antibiotics; Immunosuppressants; Other Treatments

3) By End Users: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Academic And Research Institutes; Other End Users

Subsegments:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis; Decompensated Alcoholic Cirrhosis; Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Atrophic Cirrhosis: Post-necrotic Atrophic Cirrhosis; Macronodular Atrophic Cirrhosis; Micronodular Atrophic Cirrhosis

3) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC); Secondary Biliary Cirrhosis; Autoimmune Biliary Cirrhosis

4) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis; Chronic Passive Congestion Cirrhosis; Ischemic Hepatitis Cirrhosis

5) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis; Idiopathic Cirrhosis; Metabolic Syndrome-Associated Cirrhosis

How Are Emerging Market Trends Shaping The Liver Cirrhosis Industry Landscape?

Companies operating in the liver cirrhosis market are increasingly concentrating on advancements in treatment options, such as the development of active implantable medical devices, with the aim of improving patient outcomes and expanding therapeutic possibilities. Active implantable medical devices are electronically powered implants specifically designed to monitor, support, or improve organ function within the body. For example, in December 2024, Sequana Medical NV, a Belgium-based medical device company, obtained U.S. FDA approval for its alfapump system, which is the first active implantable medical device in the U.S. for managing recurrent or refractory ascites caused by liver cirrhosis. This innovative technology offers a continuous, automated solution for fluid management by moving excess abdominal fluid to the bladder, considerably lessening reliance on invasive therapeutic paracentesis. The alfapump represents a significant advancement in enhancing patient outcomes and elevating quality of life, addressing a market of approximately 70,000 patients in the United States.

Who Are The Primary Competitors In The Global Liver Cirrhosis Market?

Major companies operating in the liver cirrhosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Viatris Inc., Grifols Therapeutics LLC, Shionogi Inc., Galectin Therapeutics Inc., NGM Biopharmaceuticals Inc., Madrigal Pharmaceuticals Inc., Akero Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

Which Regional Markets Are Contributing Most To The Liver Cirrhosis Industry Expansion?

North America was the largest region in the liver cirrhosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Liver Cirrhosis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp

Browse Through More Reports Similar to the Global Liver Cirrhosis Market 2025, By The Business Research Company

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795